Mer­ck halts prostate can­cer study while re­port­ing pos­i­tive read­out in bil­iary tract can­cer

Mer­ck is slam­ming the brakes on a late-stage Keytru­da study in prostate can­cer af­ter an in­ter­im analy­sis showed no im­prove­ment in sur­vival, the com­pa­ny an­nounced …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER